![Eric Hedrick](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eric Hedrick
Keine laufenden Positionen mehr
Vermögen: 1 Mio $ am 31.10.2023
Karriereverlauf von Eric Hedrick
Ehemalige bekannte Positionen von Eric Hedrick
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EQRX, INC. | Corporate Officer/Principal | 01.08.2020 | 09.11.2023 |
BEIGENE, LTD. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2015 | 24.08.2016 |
EPIZYME, INC. | Technik-/Wissenschafts-/F&E-Leiter | 17.05.2012 | 31.10.2014 |
PHARMACYCLICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 27.07.2011 | - |
Corporate Officer/Principal | 29.10.2010 | 13.04.2012 | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.09.2009 | 01.09.2009 |
BEIGENE, LTD. | Technik-/Wissenschafts-/F&E-Leiter | 23.01.2019 | - |
Ausbildung von Eric Hedrick
University of Maryland | Doctorate Degree |
Boston University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Cayman Islands | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 3 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BEIGENE, LTD. | Health Technology |
EQRX, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Pharmacyclics LLC
![]() Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Epizyme, Inc.
![]() Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Eric Hedrick
- Erfahrung